FDA steps up public communication on drug safety

02/26/2008 | Washington Post, The

The FDA is giving the public more information on drug safety, as evidenced by the 14 advisories it has issued since November. Paul Seligman, director of the FDA's Office of Drug Safety, said the agency is making good on HHS Secretary Mike Leavitt's pledge to promptly inform the public of the side effects of approved drugs. Rep. John Dingell, D-Mich., an FDA critic, has deemed the development "a quantum improvement."

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ